Cyrus Biotechnology Exhibits at the PEGS Protein Engineering Summit in Boston, April 8th – 11th

March 26, 2019

SEATTLE, March 26, 2019 — Cyrus Biotechnology, Inc., a biotechnology software company offering advanced protein modeling and design tools to the Biopharmaceutical, Synthetic Biology, Chemical, and Consumer Products industries is pleased to announce its participation in the 15th Annual PEGS Boston Protein Engineering Summit in Boston, from April 8th through April 11th.

Dr. David Pearlman, Senior Fellow and Director of Customer Experience at Cyrus Bio, and Rosario Caltabiano, Executive VP of Sales, will attend the conference and discuss the latest advances in in silico protein engineering at booth 539 in the Boston Seaport World Trade Center Exhibit Hall.

Cyrus Biotechnology offers commercial tools based on the well-known Rosetta protein design package. The company is a spin out of David Baker’s laboratory at the University of Washington, established to make these tools easier to deploy and use. Cyrus has implemented the Rosetta platform with an easy to use interface on a computing cloud, resulting in high reliability software with high performance, usability and security. Cyrus Bench® software, and the underlying Rosetta software package, are already leveraged by many global pharmaceutical organizations, and Cyrus customers can apply the most advanced and validated in silico protein engineering science through an intuitive user interface for:

  • Protein Structure Prediction (best overall performance at CASP and CAMEO)
  • Antibody Structure Prediction from Sequence
  • Protein Stabilization
  • Computational Affinity Maturation (Interface Design)
  • Fast Free Energy Calculations
  • Prediction of Immunogenic Epitopes
  • Removal of Identified Liabilities
  • Protein Structure Optimization and Design
  • Antibody Engineering
  • Antigen Design
  • Enzyme Design and optimization

About Cyrus Biotechnology Inc.

Cyrus Biotechnology, Inc. is a privately-held biotechnology software company offering Cyrus Bench®, a Software-as-a-Service (SaaS) platform for protein modeling and design capabilities to accelerate discovery of biologics and small molecules for the Biotechnology, Pharmaceutical, Chemical, Consumer Products and Synthetic Biology industries. Cyrus Bench® is based on the Rosetta software from the laboratory of Prof. David Baker at the University of Washington, the most powerful protein engineering software available. Cyrus customers include 10 of the top 20 Global Pharmaceutical firms and is financed by leading investors in both Technology and Biotechnology, including Trinity Ventures, Orbimed, Springrock Ventures, Alexandria Venture Investments, and W Fund.

Home